PATENT CLAIM ANALYSIS

Application Number: 15942440
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "008300"]

Abstract:
The present invention relates to a pharmaceutical composition for the prevention or treatment of diabetic neuropathy, wherein the pharmaceutical composition comprises, as active ingredients, different types of isoforms of HGF or a polynucleotide encoding the isoforms. The present invention is the first invention demonstrating that diabetic neuropathy can be prevented and treated using different types of isoforms of HGF. According to the present invention, it is possible to very effectively treat diabetic neuropathy.

Claim (Index 1):
A pharmaceutical composition for the prevention or treatment of diabetic neuropathy, the composition comprising, as active ingredients, different types of isoforms of hepatocyte growth factor (HGF) or at least one polynucleotide encoding the isoforms.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.77778
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14355792', '15030999', '12908765', '11957170', '12650860']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7588007243366569
- 35 USC 102 Novelty (BERT): 0.5944369003595154
- Combined Prediction Score: 0.7423643419389427
- Mean Citation Score: 347.34648
- Max Citation Score: 596.0432
- Similarity Product: 418.248115344429

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test